Telehealth & Digital Health

After a period of limited availability, the Ellipsys Vascular Access System is set for a 2026 relaunch, promising a less invasive option for dialysis patients.

Lipocine's stock plummets after its PPD drug fails a Phase 3 trial, but a promising signal in a patient subset offers a narrow path forward.

New platform combines genetic, epigenetic, and lab tests with AI and coaching, aiming to simplify personal health in a crowded and cautious market.

As cancer strikes younger patients, a new partnership aims to find the disease before symptoms start. But is this new technology ready for prime time?

Pantai Hospital KL's spot on Newsweek's 'World's Best' list highlights a national strategy built on superior quality, patient trust, and medical tourism.

China’s top infant formula maker is rewriting the global playbook, using cutting-edge research and local insight to challenge established giants in Southeast Asia.

The American Skin Association launches SKINsight, a podcast series uniting top doctors and patients to demystify skin disease for millions of listeners.

Up to 14.9 million Europeans suffer from chronic wounds. A new industry white paper details the staggering cost and provides a roadmap for urgent policy reform.

With its lead drug for a rare pediatric liver disease entering late-stage trials, NorthSea Therapeutics adds a veteran drug developer to its board.

A new, non-invasive therapy for men offers a faster, FDA-cleared, and Medicare-covered path to regaining bladder control after prostate surgery at home.

A new, highly selective oral drug for the most common form of dwarfism has been cleared for U.S. trials, offering hope for a more convenient treatment.

NUCOT celebrates patients thriving 25+ years post-transplant, setting new global benchmarks in survival rates through advanced care and resilience.

Merz Aesthetics secures key EU approvals for its BELOTERO® Balance filler, offering a precise, evidence-backed solution for tired eyes and forehead lines.

A new training program empowers OBGYNs to offer initial fertility services, promising to shorten patient wait times and reshape the path to starting a family.

With a fortified balance sheet and promising clinical data, Monopar Therapeutics is advancing its lead drug, ALXN1840, toward a pivotal NDA filing.

As Mochi Health takes the stage at a top women's health summit, a look behind the PR reveals a company battling rapid growth and customer complaints.

A Denver clinic now offers Therapeutic Plasma Exchange for anti-aging. But does the science back up the high-cost promise of turning back the clock?

New data reveals a slight drop in Tennessee's youth suicide rates, yet the crisis persists as a leading cause of death, sparking urgent calls for action.

A landmark partnership is scaling a 'one-drug, many-diseases' therapy, revealing how logistics, not just labs, are key to the future of medicine.

A $520K state grant will provide firefighters with a new AI-powered blood test, highlighting a major push to protect high-risk first responders.